首页> 外文期刊>Annals of vascular surgery >APACHE III score on ICU admission predicts hospital mortality after open thoracoabdominal and open abdominal aortic aneurysm repair.
【24h】

APACHE III score on ICU admission predicts hospital mortality after open thoracoabdominal and open abdominal aortic aneurysm repair.

机译:重症监护病房入院的APACHE III评分可预测胸腹开腹和腹主动脉开腹修复后的医院死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: No prior studies, to our knowledge, have examined the performance of the Acute Physiology and Chronic Health Evaluation (APACHE) III score in predicting mortality of patients undergoing open thoracoabdominal aortic aneurysm (TAAA) or open abdominal aortic aneurysm (AAA) repair. We sought to evaluate APACHE III scores in the prediction of postoperative mortality in elective TAAA and AAA repairs. METHODS: Over a 9-year period (July 1998 through June 2007), prospective data (demographics, admitting diagnosis, APACHE III score, intensive care unit [ICU] and hospital length of stay, ICU and hospital mortality) were collected by a dedicated APACHE III coordinator for all patients admitted to a tertiary academic surgical ICU (20 beds). Observational and comparative analyses were performed. Emergent repairs for ruptured aneurysms were excluded from the study. RESULTS: Forty-one patients underwent open elective repair of TAAA and 404 underwent open elective repair of AAA. Mean age of the TAAA group was 63.4 +/- 9.8 years and the AAA group was 70.3 +/- 8.3 years. Mean APACHE III score was 54 (range: 10-103) for the TAAA group and 45 (range: 11-103) for the AAA group. The in-hospital mortality rate for TAAA patients was 4.9% (n = 2) and for AAA patients was 2.0% (n = 8). Mean APACHE III scores on ICU admission were significantly greater in nonsurvivors versus survivors (79 vs. 45, p < 0.0001). For the entire patient cohort, the APACHE III score on ICU admission was an excellent discriminator of hospital mortality (receiver operating characteristic and area under the curve 0.92 [standard error of 0.05, 95% CI: 0.83-1.0]). CONCLUSIONS: APACHE III is an accurate predictor of survival to hospital discharge in both open elective TAAA and AAA repairs.
机译:背景:据我们所知,尚无先前研究检查急性生理和慢性健康评估(APACHE)III评分在预测接受开腹胸腹主动脉瘤(TAAA)或开腹腹主动脉瘤(AAA)修复的患者的死亡率方面的表现。我们试图评估APACHE III评分,以预测选择性TAAA和AAA修复的术后死亡率。方法:在9年期间(1998年7月至2007年6月),由专门的专家收集了前瞻性数据(人口统计学,入院诊断,APACHE III评分,重症监护病房[ICU]以及住院时间,ICU和死亡率)。 APACHE III协调员,适用于所有接受三级学术外科ICU(20张床位)的患者。进行观察和比较分析。本研究排除了破裂性动脉瘤的紧急修复。结果:41例患者接受了TAAA的开放性选择性修复,404例接受了AAA的开放性选择性修复。 TAAA组的平均年龄为63.4 +/- 9.8岁,AAA组为70.3 +/- 8.3岁。 TAAA组的APACHE III平均得分为54(范围:10-103),AAA组为45(范围:11-103)。 TAAA患者的院内死亡率为4.9%(n = 2),而AAA患者为2.0%(n = 8)。非幸存者和幸存者在ICU入院时的平均APACHE III评分显着更高(79比45,p <0.0001)。对于整个患者队列,ICU入院时的APACHE III评分是医院死亡率的出色判别指标(接受者的工作特征和曲线下面积0.92 [标准误为0.05,95%CI:0.83-1.0]。结论:在公开的选择性TAAA和AAA修复中,APACHE III是准确预测出院存活率的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号